University of Cambridge > > CMIH Hub seminar series > Imaging the Molecular Pathology of Alzheimer’s disease

Imaging the Molecular Pathology of Alzheimer’s disease

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Rachel Furner.

Recent advances in molecular imaging using positron emission tomography have permitted the 4-dimensional mapping of Alzheimer’s disease related pathology. The two aggregated proteins, beta-amyloid and tau, can now be visualized, along with the presumptive consequences of their deposition – brain degeneration and cognitive decline. This talk will review both cross sectional and longitudinal data concerning how tau and amyloid interact, and how they are related to neurodegeneration and cognition. The framework for discussion is a sequential model of biomarker changes. The question of whether and how well the observed data fit this model will be discussed.

This talk is part of the CMIH Hub seminar series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity